Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

MaxCyte, Inc. (MXCT) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

MaxCyte, Inc. (MXCT), most recent 12 months reported: revenue $31.05M, net loss $35.64M, free cash flow -$23.64M. Latest balance sheet on file: liquid cash $105.69M. From SEC filings. Others in Services-Commercial Physical & Biological Research: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Medpace Holdings, Inc. · NRC Health · OMNIAB, INC. · FOXO TECHNOLOGIES INC. · bioAffinity Technologies, Inc. · ABSCI CORP · ONEMEDNET CORPORATION

Stock screener

Watchlist